Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Jeroen A van Kan

Jeroen A van Kan

Professor in the Department of Physics, NUS, Singapore

Title: Development of high brightness ion sources for nuclear microprobe applications, aiming for sub 10 nm spot sizes

Biography

Biography: Jeroen A van Kan

Abstract

Microscopy and miniaturization have been an integral part of scientific progress. Since MeV protons mainly interact with substrate electrons and the fact that proton induced secondary electrons just get enough energy to break bonds, a proton beam will follow a straight path through tissue or resist material. Proton microscopy has therefore several unique advantages over other forms of microscopy. The current downside is the poor source performance, about a million times less brighter compared to electron beam sources. The success of a next generation proton microscope depends on two main components: a stable high brightness source of MeV protons and a high quality focusing lens system. We have demonstrated 9.3 x 32 nm2 proton beam focus and have written 19 nm wide (100 nm tall) lines in HSQ resist. To address the limited brightness we are developing a new ion source based on electron impact ionization. Recent tests with “on chip ion sources” have shown potential to improve the ion beam brightness by a million times. This will allow us to develop a table top proton microscope capable of delivering sub 10 nm beam spot size for MeV protons. This new source will therefore enable:

·         Sub 10 nm 3D nanofabrication without “proximity effects”.

·         Sub 10 nm whole cell imaging, opening up new pathways to investigate the uptake of nanoparticles in drugs delivery.

·         Since 0.5 MeV protons will cause double stand breaks in DNA, this new system will provide an insight to improve cancer treatment in radiobiology using 200 MeV protons.